Revolutionizing Chronic Care: myBiometry Secures $5 Million in Seed Funding

We are thrilled to announce that myBiometry has successfully raised $5 million in our latest funding round, a significant milestone that will propel our mission to redefine chronic condition management. As a pioneering platform dedicated to remotely monitoring and managing patients with chronic conditions, myBiometry leverages cutting-edge software and proprietary sensors to gather biomarker data that enhances patient care and outcomes. Our initial focus on asthma addresses the pressing need for innovative solutions in this area, where countless individuals struggle with symptom management and medication adherence. The infusion of capital will enable us to enhance our technology infrastructure, expand our product capabilities, and ultimately develop a more comprehensive solution for asthma management. We plan to invest in research and development to refine our sensors and software features, ensuring our platform delivers accurate, actionable insights that empower patients and healthcare providers alike. Furthermore, this funding will allow us to scale our outreach efforts, fostering partnerships with healthcare institutions and providers to make our solutions widely accessible. As we move forward, we remain committed to transforming chronic disease management through evidence-based personalized care, and we are excited to broaden our impact in the coming months. Thank you to all our investors and supporters for believing in our vision; together, we are making strides toward a healthier future for asthma patients around the world.